Different Impact of Excision Repair Cross-Complementing Group 1 on Survival

被引：2
|
作者：
Panasci, Lawrence C. [1 ,2 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Jewish Gen Hosp, Dept Oncol, Montreal, PQ H3T 1E2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 10期
关键词：
CELL LUNG-CANCER;
D O I：
10.1200/JCO.2009.26.6619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E163 / E163
页数：1
相关论文
共 50 条
  • [21] Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population
    Ma, Hongxia
    Xu, Liang
    Yuan, Jing
    Shao, Minhua
    Hu, Zhibin
    Wang, Feng
    Wang, Yi
    Yuan, Wentao
    Qian, Ji
    Wang, Ying
    Xun, Pengcheng
    Liu, Hongliang
    Chen, Weihong
    Yang, Lin
    Jin, Guangfu
    Huo, Xiang
    Chen, Feng
    Shugart, Yin Yao
    Jin, Li
    Wei, Qingyi
    Wu, Tangchun
    Shen, Hongbing
    Huang, Wei
    Lu, Daru
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (06): : 417 - 423
  • [22] EXPRESSION OF THE EXCISION-REPAIR GENE, ERCC3 (EXCISION-REPAIR CROSS-COMPLEMENTING), DURING MOUSE DEVELOPMENT
    HUBANK, M
    MAYNE, L
    DEVELOPMENTAL BRAIN RESEARCH, 1994, 81 (01): : 66 - 76
  • [23] Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer
    Hermawan, Adam
    Putri, Herwandhani
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2023, 12 (01)
  • [24] Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer
    Adam Hermawan
    Herwandhani Putri
    Beni-Suef University Journal of Basic and Applied Sciences, 12
  • [25] Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients
    Zhao, Menghuang
    Li, Saisai
    Zhou, Lulu
    Shen, Qi
    Zhu, Haiyan
    Zhu, Xueqiong
    LIFE SCIENCES, 2018, 194 : 34 - 39
  • [26] Association of Genetic Variations in X-Ray Repair Cross-Complementing Group 1 and Tourette Syndrome
    Lin, Wei-Yong
    Lee, Cheng-Chun
    Liu, Hsin-Ping
    Chou, I-Ching
    Sheu, Jim Jinn-Chyuan
    Wan, Lei
    Lin, Ying-Ju
    Tsai, Yuhsin
    Tsai, Fuu-Jen
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2012, 26 (05) : 321 - 324
  • [27] Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response
    Felip, Enriqueta
    Rosell, Rafael
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (03) : 261 - 268
  • [28] Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
    Peng, Haiying
    Yao, Shaobo
    Dong, Qingyu
    Zhang, Yanxia
    Gong, Weihong
    Jia, Zhongyao
    Yan, Li
    MEDICINE, 2018, 97 (31)
  • [29] ERCC1 (Excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor
    Roa, Ivan
    de Aretxabala, Xabier
    Lantadilla, Soledad
    Munoz, Sergio
    HISTOLOGY AND HISTOPATHOLOGY, 2011, 26 (01) : 37 - 43
  • [30] Excision repair cross-complementing group-1 (ERCC1) induction and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
    Rao, Devika
    Mallick, Atrayee Basu
    Augustine, Titto
    Daroqui, Cecilia
    Jiffry, Jeeshan
    Merla, Amartej
    Chaudhary, Imran
    Seetharaman, Raviraja
    Sood, Arjun
    Gajavelli, Srikanth
    Aparo, Santiago
    Rajdev, Lakshmi
    Kaubisch, Andreas
    Chuy, Jennifer
    Maitra, Radhashree
    Goel, Sanjay
    CANCER RESEARCH, 2019, 79 (13)
12345